CAR-T therapy and chimeric antigen receptor

CAR-T therapy and chimeric antigen receptor

0 0 about 1 year ago
0 Plays 0 Downloads
Although CD19 CAR T immunotherapy is still immature, many research centers have begun to accumulate and report on the important experience of CAR-T cells in the treatment of B-cell malignancies related to production and effective delivery of CAR-T cells. We hope to find out the main influencing factors affecting the outcome of CAR-T cell immunotherapy by comparing different clinical trial data. It should be noted that the production strategy including the separation and stimulation of T cells, ... See More

Find us on Facebook

iAB member
Copyright 2019 - Spreaker Inc. a Voxnest Company - Create a podcast - New York, NY
Help